We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+7.96%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$78.8B
AUM Growth
-$135M
(-0.17%)
Cap. Flow
-$4.13B
Cap. Flow
% of AUM
-5.25%
Top 10 Holdings %
Top 10 Hldgs %
14.64%
Holding
3,669
New
809
Increased
1,002
Reduced
1,102
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$807M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$497M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$390M |
| 4 |
Kenvue
KVUE
|
+$379M |
| 5 |
Broadcom
AVGO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$409M |
| 2 |
Visa
V
|
+$354M |
| 3 |
Advanced Micro Devices
AMD
|
+$328M |
| 4 |
Meta Platforms (Facebook)
META
|
+$317M |
| 5 |
Lockheed Martin
LMT
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.61% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Healthcare | 8.17% |
| 4 | Industrials | 8.1% |
| 5 | Financials | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Carter's
CRI
$1.46B
| $13.4M | 0.02% |
414,711
+279,362
| +206% | +$8.72M |
|
852
Carlyle Group
CG
$17.6B
| $13.4M | 0.02% |
226,712
-979,221
| -81% | -$55.6M |
|
853
KBR
KBR
$4.78B
| $13.4M | 0.02% |
+333,115
| New | +$14.3M |
|
854
PUT
Invesco S&P 500 Equal Weight ETF
RSP
$99.3B
| $13.4M | 0.02% |
+69,900
| New | +$13.3M |
|
855
Liberty Live Group Series C
LLYVK
$9.62B
| $13.2M | 0.02% |
+159,114
| New | +$13.7M |
|
856
Silicon Motion
SIMO
$7.64B
| $13.2M | 0.02% |
142,561
+15,254
| +12% | +$1.4M |
|
|
NOVTU
857
Novanta Inc Units
NOVTU
$764M
| $13.2M | 0.02% |
+240,000
| New | +$12.7M |
|
858
Hamilton Insurance Group
HG
$3.47B
| $13.2M | 0.02% |
472,149
+157,583
| +50% | +$4.09M |
|
859
PUT
UnitedHealth
UNH
$366B
| $13.2M | 0.02% |
39,900
-10,600
| -21% | -$3.59M |
|
860
CALL
AstraZeneca
AZN
$247B
| $13.2M | 0.02% |
71,600
+45,300
| +172% | +$7.94M |
|
861
PUT
iShares MSCI Brazil ETF
EWZ
$8.6B
| $13.1M | 0.02% |
413,500
-24,700
| -6% | -$781K |
|
862
Comcast
CMCSA
$90.6B
| $13.1M | 0.02% |
438,891
+399,690
| +1,020% | +$11.4M |
|
863
nCino
NCNO
$2.1B
| $13.1M | 0.02% |
511,226
-1,492,407
| -74% | -$37.9M |
|
864
Tenable Holdings
TENB
$4.16B
| $13.1M | 0.02% |
+555,225
| New | +$15.2M |
|
865
LCI Industries
LCII
$2.6B
| $13M | 0.02% |
+107,515
| New | +$11.4M |
|
866
Huntington Bancshares
HBAN
$35.9B
| $13M | 0.02% |
749,465
+514,693
| +219% | +$8.45M |
|
867
PUT
Robinhood
HOOD
$84.1B
| $13M | 0.02% |
114,900
-92,700
| -45% | -$12.1M |
|
868
Factset
FDS
$10.1B
| $13M | 0.02% |
+44,712
| New | +$12.6M |
|
869
QuinStreet
QNST
$1.18B
| $12.9M | 0.02% |
+900,264
| New | +$13M |
|
870
iShares MSCI South Korea ETF
EWY
$25.7B
| $12.9M | 0.02% |
+132,318
| New | +$12.1M |
|
871
PUT
SPDR Gold Trust
GLD
$143B
| $12.8M | 0.02% |
32,400
+14,400
| +80% | +$5.5M |
|
872
ArcelorMittal
MT
$55.7B
| $12.8M | 0.02% |
280,869
-88,115
| -24% | -$3.62M |
|
873
Accenture
ACN
$109B
| $12.8M | 0.02% |
47,563
-50,418
| -51% | -$12.8M |
|
874
Scorpio Tankers
STNG
$3.72B
| $12.7M | 0.02% |
250,298
+98,676
| +65% | +$5.63M |
|
875
CALL
Dollar Tree
DLTR
$24.5B
| $12.7M | 0.02% |
103,400
-1,700
| -2% | -$182K |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q4 2025 Portfolio in Review
As of Q4 2025, Balyasny Asset Management held 3,669 positions worth $78.8B, down 0.17% from $78.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Balyasny Asset Management withdrew a net $4.13B in Q4 2025, closing 643 positions and reducing 1,102 holdings. Its most notable exit was Mr. Cooper, an estimated $277M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Balyasny Asset Management opened a new position in Avidity Biosciences worth $436M.
- Balyasny Asset Management's largest Q4 2025 buy was Avidity Biosciences: 6,040,590 shares worth $436M.
- Balyasny Asset Management added most to Amazon in Q4 2025, an estimated $807M increase.
- Balyasny Asset Management's biggest Q4 2025 reduction was Apple, cutting an estimated $409M.
- Balyasny Asset Management fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Balyasny Asset Management's ten largest holdings make up 15% of its $78.8B portfolio in Q4 2025.
- Balyasny Asset Management opened 809 new positions and closed 643 in Q4 2025.
- Balyasny Asset Management's portfolio value fell 0.17% quarter-over-quarter to $78.8B.
Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.